Butterfly Learnings is a paediatric behavioural health startup based in Mumbai, India, that runs therapy centres and a technology platform for children with neurodevelopmental conditions.

This Startup Deep Dive explains what Butterfly Learnings does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Butterfly Learnings in Brief

• What it is: Butterfly Learnings is an Indian Paediatric neurodevelopmental care company based in Mumbai.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Butterfly Learnings runs centres providing care for children with autism, ADHD, learning disabilities and other neurodevelopmental conditions.
• It reportedly runs more than 90 centres across over 22 Indian cities, plus a therapist training institute.
• Its offering combines clinical therapy (ABA, speech and occupational therapy, sensory integration), inclusive schooling, diagnostics and digital therapeutics.
• Funding: About USD 12 million: roughly USD 5 million raised Aug 2022 to Mar 2024 plus Rs 65 crore (USD 6.7 million) pre-Series B (reported).

Butterfly Learnings Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Butterfly Learnings?

Butterfly Learnings operates in the Paediatric neurodevelopmental care space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Butterfly Learnings.

• Butterfly Learnings runs centres providing care for children with autism, ADHD, learning disabilities and other neurodevelopmental conditions.
• It reportedly runs more than 90 centres across over 22 Indian cities, plus a therapist training institute.
• Its offering combines clinical therapy (ABA, speech and occupational therapy, sensory integration), inclusive schooling, diagnostics and digital therapeutics.
• It licenses Get SET Early, an eye-tracking autism screening technology, on an exclusive worldwide basis (reported).

The Origin Story of Butterfly Learnings

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Dr Sonam Kothari, Dr Abhishek Sen.
• Dr Sonam Kothari is a paediatric neurologist and board-certified behaviour analyst, and CEO.
• Dr Abhishek Sen is a serial healthcare entrepreneur who earlier built and exited medtech startup Biosense Technologies; the 2019 exit funded the venture.
• The first centre opened in Thane, Mumbai, around 2021, and the company reportedly had four centres across Mumbai and Thane at its 2022 seed round.
• The aim was to address fragmented care for families of children with neurodevelopmental conditions.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Paediatric neurodevelopmental care sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2021: first centre opened in Thane.
• 2022: seed round of about $1.5 million (another report says $2 million), with four centres.
• April 2024: Series A of Rs 32 crore (about $3.8 million) led by Insitor Impact Asia Fund II and Enzia Ventures; about 2,000 families across 30 centres in Maharashtra at the time.
• May 2025: BLISS inclusive schooling system expanded into K-12, with a first cohort of 70 students and a goal of 100 schools in five years (reported).
• August 2026: Rs 65 crore pre-Series B led by Inflexor Ventures; 90+ centres in 22+ cities.

Butterfly Learnings Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Seed round of $1.5 million in 2022 from investors including Insitor Partners, 9Unicorns, Venture Catalysts, Fondation Botnar, UTIL Stiftung and CIIE.CO (reported; another report says USD 2 million).
• April 2024: Series A of Rs 32 crore led by Insitor Impact Asia Fund II and Enzia Ventures, with IIMA Ventures, Fondation Botnar, 9Unicorns and Venture Catalysts.
• August 2026: pre-Series B of Rs 65 crore (USD 6.7 million) led by Inflexor Ventures, with Enzia Ventures, Insitor Impact Asia Fund and IIMA Ventures participating (reported; reports differ on the exact Insitor entity and on whether IIMA Ventures is listed).

How Does Butterfly Learnings Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Revenue comes from fees for therapy sessions and programmes at its physical centres.
• It adds inclusive schooling (BLISS), diagnostics and a therapist training institute.
• Get SET Early is to be commercialised through hospitals and paediatricians.
• In-house therapist training supports centre rollout.

The Numbers: Butterfly Learnings Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• FY24: operating revenue about Rs 6.3 crore (profile site).
• FY25: operating income about Rs 14 crore (Venture Intelligence) or Rs 15.5 crore (profile site); net loss about Rs 13 crore.

Market Opportunity for Butterfly Learnings

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• The company targets care for children with autism, ADHD and learning disabilities, where therapy access is fragmented.
• It is expanding beyond its Maharashtra base to other states.

Technology and Product at Butterfly Learnings

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Get SET Early is a patented eye-tracking autism screening tool; after CDSCO approval it is designed to screen children from as young as one year.
• Funds also go toward technology and AI capabilities and digital therapeutics.

Team and Culture at Butterfly Learnings

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Co-founders are Dr Sonam Kothari (CEO) and Dr Abhishek Sen.
• A profile site lists about 359 employees.

Butterfly Learnings Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Butterfly Learnings

• Growth depends on opening new physical centres, which the new funding is earmarked for alongside its tech platform and screening tool commercialisation.
• FY25 net loss of about Rs 13 crore against about Rs 14 crore of revenue shows heavy spending ahead of scale.
• Get SET Early depends on regulatory approval and adoption by paediatricians.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Butterfly Learnings Growth Outlook: What to Watch

• Funds are reportedly meant for new centres, its technology platform, and bringing the autism screening tool to market.
• The Series A plan was to reach 200 centres.
• Expansion outside Maharashtra is a stated priority.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Butterfly Learnings can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Butterfly Learnings Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Butterfly Learnings

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Butterfly Learnings.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Butterfly Learnings

Studying a company in the Paediatric neurodevelopmental care space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Butterfly Learnings.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Butterfly Learnings as a Startup

• Customer clarity: Can Butterfly Learnings name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Butterfly Learnings is part of India’s growing Paediatric neurodevelopmental care ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Butterfly Learnings FAQs: Frequently Asked Questions

What is Butterfly Learnings?

Butterfly Learnings is a paediatric behavioural health startup based in Mumbai, India, that runs therapy centres and a technology platform for children with neurodevelopmental conditions. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Butterfly Learnings?

Butterfly Learnings was founded by Dr Sonam Kothari, Dr Abhishek Sen, and the company reports a founding year of 2021 (reports differ: 2022 in some coverage).

How much funding has Butterfly Learnings raised?

About USD 12 million: roughly USD 5 million raised Aug 2022 to Mar 2024 plus Rs 65 crore (USD 6.7 million) pre-Series B (reported). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Butterfly Learnings make money?

Butterfly Learnings earns revenue from its Paediatric neurodevelopmental care products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Butterfly Learnings?

Reported rivals include Daffodil Health, Mom's Belief, Kinderpass, Lissun. See the competitor comparison above for how they differ.

What are the main risks for Butterfly Learnings?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Blurgs AI — Blurgs AI raises a reported $2.2M for maritime and defence AI | Hearzap — Hearzap: from Rs 50 Cr Series A to buying Amplifon India, 420 centres. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.